HSPG2 and hepatocellular carcinoma: On the contrary, it has been reported that inhibition of expression of S1P lyase, which catalyzes S1P to an inactive product, leads to reduce migration and invasion of PLC/PRF/5 cells [35], and reduction of S1P levels in human HCC tissues is associated with early recurrence [35].